436 Search Results for VA Clinicians
The development of multiple biologic agents for the treatment of rheumatoid arthritis (RA) in recent years has given patients and clinicians more options for therapy.
An estimated 5-10% of all cutaneous T-cell lymphoma (CTCL) diagnosed each year occurs in veterans treated by the VA. The cancer, classified as presumptively caused by Agent Orange exposure, is notoriously difficult to diagnose and... View Article
By Brenda L. Mooney COLUMBIA, SC — Veterans prescribed amoxicillin over a nearly 13-year period were less likely to be diagnosed with potentially fatal heart rhythms than those using either azithromycin or levofloxacin, according to... View Article
By Annette M. Boyle David Ross, MD, PhD WASHINGTON — New therapies for hepatitis C (HCV) are pouring out of the pharmaceutical pipeline and promising effective treatment with fewer side effects for many of the... View Article
By Sandra Basu WASHINGTON — With stricter oversight of government conference spending, medical and pharmacy components within DoD and VA are working to ensure providers are still getting their necessary continuing medical education. “In response... View Article
By Stephen Spotswood WASHINGTON — The past few years have seen a revolution in personal technology. Smartphones and tablet computers have made all the functions of the personal computer and the Internet completely portable and... View Article
By Annette M. Boyle WASHINGTON—Concerned about how much time clinicians spend reading and responding to emails, the VA is changing its messaging system so that more of their focus can be on patient care. The... View Article
VA is falling short on its goals to hire more mental health professionals by the end of this year, VA Secretary David Shulkin, MD, told legislators at a recent Senate hearing on suicide prevention.
Testosterone prescribing at the VHA has followed national trends and increased substantially over the last decade.
VA clinicians and their patients might find themselves in a difficult position related to proposed opioid prescribing guidelines from the national Centers for Disease Control and Prevention (CDC).
By Sandra Basu WASHINGTON – As a general internist at the Boston VA, Ashish Jha, MD, MPH, believes that the voices of VA physicians are of critical importance in shaping veterans’ care in the future. “Now that... View Article
WASHINGTON — Use of novel anticoagulants has risen sharply both at the VA and in the Army in the last three years, freeing more atrial fibrillation patients from food restrictions and regular checks for coagulation time, as required when using warfarin.
PHILADELPHIA—Building on the success of the Parkinson’s Disease Research, Education and Clinical Centers, established in 2001, the VA has expanded care for the nearly 100,000 veterans affected by the neurodegenerative disease through the creation of... View Article
HOUSTON—Anemia is a common complication of inflammatory bowel disease, and existing guidelines urge vigilance for the condition. Yet, according to a study in Digestive Diseases & Sciences, it is frequently undertreated, resulting in the prevalence... View Article
CHICAGO—No healthcare system has been more affected by the dramatic rise in hepatocellular carcinoma than the VA. In 2000, the VA had 1,361 patients diagnosed with the disease. By 2005, the number of veterans diagnosed... View Article
CHICAGO—The profusion of data available through electronic health records and genomic analyses can guide lung cancer treatment—if clinicians can access key points quickly enough. Researchers at the Boston VAMC and their colleagues found a way... View Article
CHICAGO—VA researchers have mapped the most common subsequent diagnoses for veterans diagnosed with several common cancers, allowing clinicians to better personalize care and focus prevention efforts. The study, which enabled creation of a network graph... View Article
A new study looks at factors to improve survival rates in veterans with multiple sclerosis. VA’s efforts don’t stop there, however. The healthcare system has a multipronged effort to reduce disability and improve quality of... View Article
Because of their cardiovascular protective effects, SGLT2 inhibitors have been a game-changer in Type 2 diabetes treatment. That is especially the case, now that the FDA has approved a new indication for canagliflozin to reduce... View Article
With veterans at generally higher risk of lung cancer for a variety of reasons, the VA is seeking to catch cases earlier by instituting widespread screening. The healthcare system is facing a difficult challenge, however:... View Article